Literature DB >> 3373023

Efficacy of ciprofloxacin in the treatment of chronic typhoid carriers.

C Ferreccio1, J G Morris, C Valdivieso, I Prenzel, V Sotomayor, G L Drusano, M M Levine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3373023     DOI： 10.1093/infdis/157.6.1235

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  28 in total

1.  Acalculous acute cholecystitis due to Salmonella typhi.

Authors:  M E Avalos; M A Cerulli; R S Lee
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

Review 2.  Tropical medicine.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

3.  Efficacy of the combination pivampicillin/pivmecillinam compared to placebo in the treatment of convalescent carriers of nontyphi Salmonella.

Authors:  B Svenungsson; E Ekwall; H B Hansson
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

4.  Acute acalculous cholecystitis due to Salmonella.

Authors:  P Garrido-Benedicto; E González-Reimers; F Santolaria-Fernández; F Rodríguez-Moreno
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

Review 5.  Quinolones in Salmonella typhi infection.

Authors:  H L DuPont
Journal:  Drugs       Date:  1993       Impact factor: 9.546

6.  Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever.

Authors:  M R Wallace; A A Yousif; G A Mahroos; T Mapes; E J Threlfall; B Rowe; K C Hyams
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

Review 7.  Current trends in typhoid Fever.

Authors:  Nancy F Crum
Journal:  Curr Gastroenterol Rep       Date:  2003-08

8.  Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.

Authors:  T J Louie
Journal:  CMAJ       Date:  1994-03-01       Impact factor: 8.262

Review 9.  Fluoroquinolones in the treatment of typhoid fever and the carrier state.

Authors:  I Zavala Trujillo; C Quiroz; M A Gutierrez; J Arias; M Renteria
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

10.  In vitro activities of tosufloxacin, temafloxacin, and A-56620 against pathogens of diarrhea.

Authors:  J P Bryan; C Waters; J Sheffield; R E Krieg; P L Perine; K Wagner
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.